Edgewise Therapeutics Inc
NASDAQ:EWTX

Watchlist Manager
Edgewise Therapeutics Inc Logo
Edgewise Therapeutics Inc
NASDAQ:EWTX
Watchlist
Price: 24.62 USD -6.57%
Market Cap: 2.6B USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of EWTX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EWTX Intrinsic Value
Not Available
Base Case Scenario
Compare EWTX to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EWTX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Edgewise Therapeutics Inc

Current Assets 573.9m
Cash & Short-Term Investments 563.3m
Other Current Assets 10.6m
Non-Current Assets 9.6m
PP&E 9.6m
Current Liabilities 21.6m
Accounts Payable 6.2m
Accrued Liabilities 15.5m
Non-Current Liabilities 3.2m
Other Non-Current Liabilities 3.2m
Efficiency

Free Cash Flow Analysis
Edgewise Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Edgewise Therapeutics Inc

Revenue
0 USD
Operating Expenses
-181m USD
Operating Income
-181m USD
Other Expenses
23.7m USD
Net Income
-157.2m USD
Fundamental Scores

EWTX Profitability Score
Profitability Due Diligence

Edgewise Therapeutics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
28/100
Profitability
Score

Edgewise Therapeutics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

EWTX Solvency Score
Solvency Due Diligence

Edgewise Therapeutics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Edgewise Therapeutics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EWTX Price Targets Summary
Edgewise Therapeutics Inc

Wall Street analysts forecast EWTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EWTX is 38.93 USD with a low forecast of 16.16 USD and a high forecast of 53.55 USD.

Lowest
Price Target
16.16 USD
34% Downside
Average
Price Target
38.93 USD
58% Upside
Highest
Price Target
53.55 USD
118% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Edgewise Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for EWTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

EWTX Insider Trading
Buy and sell transactions by insiders

EWTX News

Other Videos